Ferreras, Cristina; Hernandez-Blanco, Clara; Martin-Quiros, Alejandro; Al-Akioui-Sanz, Karima; Mora-Rillo, Marta; Ibanez, Fatima; Diaz-Almiron, Mariana; Cano-Ochando, Jordi; Lozano-Ojalvo, Daniel; Jimenez-Gonzalez, Maria; Goterris, Rosa; Sanchez-Zapardiel, Elena; de Paz, Raquel; Guerra-Garcia, Pilar; Queiruga-Parada, Javier; Molina, Pablo; Briones, Maria Luisa; Ruz-Caracuel, Beatriz; Borobia, Alberto M.; Carcas, Antonio J.; Planelles, Dolores; Vicario, Jose Luis; Moreno, Miguel Angel; Balas, Antonio; Llano, Marta; Llorente, Andrea; del Balzo, Alvaro; Canada, Carlos; Garcia, Miguel Angel; Calvin, Maria Elena; Arenas, Isabel; de Diego, Rebeca Perez; Eguizabal, Cristina; Soria, Bernat; Solano, Carlos; Perez-Martinez, Antonio

Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challenges

在临床试验中实施药物遗传学: 关于当前方法学，伦理和监管挑战的考虑

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2023-12-250

PRE

Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2023-10-271

The Current Mismatch Between Coronavirus Disease 2019 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis

CLINICAL INFECTIOUS DISEASES

IF7.3

2023-10-262

PRE

Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2023-10-110

OAAI

Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-09-291

OAAI

Rationale for combined therapies in severe-to-critical COVID-19 patients

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-09-111

OAAI

Gonzaga, Aitor; Andreu, Etelvina; Hernandez-Blasco, Luis M.; Meseguer, Rut; Al-Akioui-Sanz, Karima; Soria-Juan, Barbara; Sanjuan-Gimenez, Jose Carlos; Ferreras, Cristina; Tejedo, Juan R.; Lopez-Lluch, Guillermo; Goterris, Rosa; Macia, Loreto; Sempere-Ortells, Jose M.; Hmadcha, Abdelkrim; Borobia, Alberto; Vicario, Jose L.; Bonora, Ana; Aguilar-Gallardo, Cristobal; Poveda, Jose L.; Arbona, Cristina; Alenda, Cristina; Tarin, Fabian; Marco, Francisco M.; Merino, Esperanza; Jaime, Francisco; Ferreres, Jose; Figueira, Juan Carlos; Canada-Illana, Carlos; Querol, Sergio; Guerreiro, Manuel; Eguizabal, Cristina; Martin-Quiros, Alejandro; Robles-Marhuenda, Angel; Perez-Martinez, Antonio; Solano, Carlos; Soria, Bernat

Clinical research with targeted drugs in paediatric oncology

DRUG DISCOVERY TODAY

IF7.5

2023-08-012

PRE

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

基于蛋白质的PHH-1V与BNT162b2作为异源SARS-CoV-2加强疫苗在成人新型冠状病毒肺炎疫苗中的安全性和免疫原性比较: 多中心，随机，双盲，非劣效性IIb期试验

LANCET REGIONAL HEALTH-EUROPE

IF13

2023-05-0116

Corominas, Julia; Garriga, Carme; Prenafeta, Antoni; Moros, Alexandra; Canete, Manuel; Barreiro, Antonio; Gonzalez-Gonzalez, Luis; Madrenas, Laia; Guell, Irina; Clotet, Bonaventura; Izquierdo-Useros, Nuria; Raich-Regue, Dalia; Gallemi, Marcal; Blanco, Julia; Pradenas, Edwards; Trinite, Benjamin; Prado, Julia G.; Blanch-Lombarte, Oscar; Perez-Caballero, Raul; Plana, Montserrat; Esteban, Ignasi; Pastor-Quinones, Carmen; Nunez-Costa, Xavier; Abu Taleb, Rachel; McSkimming, Paula; Soriano, Alex; Nava, Jocelyn; Anagua, Jesse Omar; Ramos, Rafel; Lluch, Ruth Marti; Comes, Aida Corpes; Romero, Susana Otero; Gomez, Xavier Martinez; Sans-Pola, Carla; Molto, Jose; Benet, Susana; Bailon, Lucia; Arribas, Jose R.; Borobia, Alberto M.; Parada, Javier Queiruga; Navarro-Perez, Jorge; Giner, Maria Jose Forner; Lucas, Rafael Orti; Jimenez, Maria del Mar Vazquez; Compan, Salvador Ona; Alvarez-Mon, Melchor; Troncoso, Daniel; Arana-Arri, Eunate; Meijide, Susana; Imaz-Ayo, Natale; Garcia, Patricia Munoz; Martinez, Sofia de la Villa; Fernandez, Sara Rodriguez; Prat, Teresa; Torroella, Elia; Ferrer, Laura

Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2023-03-281

OAAI

No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2023-01-010

OAAI

Alberto M. Borobia

个人简介

教育背景

工作经历

荣誉奖项

研究方向